Linked In       FaceBook       Twitter       You Tube
Champ
Podio
Project management using Podio

 

more information

Advocacy Home Page

AMP Press Releases

AMP Position Statements and Letters

 

 

 

 

AMP Position statements and letters

AMP Position Statements and Letters - 2010

 

2010 Title Keywords Committee
       

October

Comments to the SACGHS re: Whole Genome Sequencing

 

Whole Genome Analysis Working Group

 

Letter to FDA Expressing Concerns Over Potential Medical Device Registration Requirement

 

Multi-Association Coalition

       

September

Letter to FDA Encouraging Continued Dialogue re: LDTs

 

Multi-Association Coalition

       

July

Comments to NIH regarding the Genetic Test Registry

 

Professional Relations

 

Comments to FDA regarding oversight of laboratory developed tests

 

Professional Relations

 

 

 

 

June

Comments to SACGHS regarding the draft report on Genetics Education and Training

 

Professional Relations

 

Comments to FDA regarding regulation of cytogenetic arrays

 

Arrays Working Group

 

Comments to FDA CDRH Council regarding barriers to market for molecular diagnostic tests

 

Professional Relations

 

Comments to SACGHS regarding Whole Genome Sequencing

 

Clinical Practice

 

 

 

 

February

Comments to the SACGHS to finalize gene patent report and recommendations as presented in October 2009

 

Professional Relations

 

 

 

 

  Comments to AHRQ on the draft Technology Assessment, "Systematic Reviews on Selected Pharmacogenetic Tests for Cancer Treatment"   Professional Relations
       

January

AMP's position on the oversight of laboratory developed tests (LDTs) released and discussed with FDA

 

Professional Relations

 

AMP presents to MEDCAC regarding pharmacogenomic testing

 

Professional Relations